Zero Candida (the ‘Company’ or ‘ZC’) (TSXV: ZCT), an Israeli FemTech medical device start-up, is pleased to announce the Company...
Read moreGold saw incredible price gains in 2024, rising from US$2,000 per ounce to close to US$2,800. Various factors have lent...
Read moreThe cryptocurrency market has experienced a remarkable transformation over the past year, marked by strong investor interest and a significant...
Read moreTartana Minerals (TAT:AU) has announced Capital Raising and QSM Completion Update Download the PDF here. This post appeared first on...
Read moreCleo Diagnostics (COV:AU) has announced CLEO Further Expands Ovarian Cancer Trial with Siles Health Download the PDF here. This post...
Read moreLundin Mining (TSX:LUN,OTC Pink:LUNMF) has entered a definitive agreement to sell its Neves-Corvo operation in Portugal and Zinkgruvan operation in...
Read moreRadiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402 Download the PDF here. This post appeared...
Read moreThe Trump administration’s ability to reign in government spending, quash inflation and bolster the economy were the most prevalent topics...
Read moreAs gold and silver continue to prove their worth as sound investments, market participants should know how precious metals investments...
Read moreS2 Resources (ASX:S2R) said Wednesday (December 4) that it has signed an earn-in deal with Valkea Resources (TSXV:OZ,OTCQB:OZBKF) as part...
Read moreDisclaimer: fundfluxes.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Copyright © 2024 fundfluxes.com | All Rights Reserved